Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T1UJ
|
||||
Former ID |
DAP001195
|
||||
Drug Name |
Reteplase
|
||||
Synonyms |
Retevase; Rapilysin (TN); Retavase (TN); Retevase (TN); Reteplase (USAN/INN)
|
||||
Therapeutic Class |
Thrombolytic Agents
|
||||
Formula |
C1736H2671N499O522S22
|
||||
CAS Number |
CAS 133652-38-7
|
||||
PubChem Substance ID | |||||
SuperDrug ATC ID |
B01AD07
|
||||
Target and Pathway | |||||
Target(s) | Plasminogen | Target Info | Activator | [536348], [536795] | |
PANTHER Pathway | Blood coagulation | ||||
Plasminogen activating cascade | |||||
PathWhiz Pathway | Coagulation | ||||
WikiPathways | Complement and Coagulation Cascades | ||||
Human Complement System | |||||
Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | |||||
Activation of Matrix Metalloproteinases | |||||
Blood Clotting Cascade | |||||
Dissolution of Fibrin Clot | |||||
Folate Metabolism | |||||
Vitamin B12 Metabolism | |||||
Selenium Micronutrient Network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.